263 related articles for article (PubMed ID: 32051302)
1. Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.
Sun H; Wang H; Shi L; Wang M; Li J; Shi J; Ni M; Hu X; Chen Y
BMJ Open; 2020 Feb; 10(2):e032336. PubMed ID: 32051302
[TBL] [Abstract][Full Text] [Related]
2. Patient Preferences For Chemotherapy In The Treatment Of Non-Small Cell Lung Cancer: A Multicenter Discrete Choice Experiment (DCE) Study In China.
Sun H; Wang H; Xu N; Li J; Shi J; Zhou N; Ni M; Hu X; Chen Y
Patient Prefer Adherence; 2019; 13():1701-1709. PubMed ID: 31631985
[TBL] [Abstract][Full Text] [Related]
3. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
Front Public Health; 2021; 9():653450. PubMed ID: 33842426
[No Abstract] [Full Text] [Related]
4. Physician Preferences and Shared-Decision Making for the Traditional Chinese Medicine Treatment of Lung Cancer: A Discrete-Choice Experiment Study in China.
Yan J; Wei Y; Teng Y; Liu S; Li F; Bao S; Ren Y; Chen Y
Patient Prefer Adherence; 2022; 16():1487-1497. PubMed ID: 35747587
[TBL] [Abstract][Full Text] [Related]
5. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
[TBL] [Abstract][Full Text] [Related]
6. Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis.
Bridges JF; Mohamed AF; Finnern HW; Woehl A; Hauber AB
Lung Cancer; 2012 Jul; 77(1):224-31. PubMed ID: 22369719
[TBL] [Abstract][Full Text] [Related]
7. Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer.
Bridges JF; la Cruz M; Pavilack M; Flood E; Janssen EM; Chehab N; Fernandes AW
Future Oncol; 2019 Dec; 15(34):3895-3907. PubMed ID: 31621403
[No Abstract] [Full Text] [Related]
8. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment.
Wong XY; Lim AQJ; Shen Q; Chia JWK; Chew MH; Tan WS; Wee HL
Curr Med Res Opin; 2020 Oct; 36(10):1677-1686. PubMed ID: 32609014
[TBL] [Abstract][Full Text] [Related]
10. Patient versus physician preferences for lipid-lowering drug therapy: A discrete choice experiment.
Zhang L; Chen J; Cao Z; Zhang M; Ma R; Zhang P; Yao G; Li X
Health Expect; 2024 Apr; 27(2):e14043. PubMed ID: 38590082
[TBL] [Abstract][Full Text] [Related]
11. Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experiment.
Protiere C; Arnold M; Fiorentino M; Fressard L; Lelièvre JD; Mimi M; Raffi F; Mora M; Meyer L; Sagaon-Teyssier L; Zucman D; Préau M; Lambotte O; Spire B; Suzan-Monti M;
J Int AIDS Soc; 2020 Feb; 23(2):e25443. PubMed ID: 32077248
[TBL] [Abstract][Full Text] [Related]
12. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
[TBL] [Abstract][Full Text] [Related]
13. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.
Veldwijk J; Smith IP; Oliveri S; Petrocchi S; Smith MY; Lanzoni L; Janssens R; Huys I; de Wit GA; Groothuis-Oudshoorn CGM
Med Decis Making; 2024 Feb; 44(2):203-216. PubMed ID: 38178591
[TBL] [Abstract][Full Text] [Related]
14. Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.
Liu T; Tsang W; Huang F; Lau OY; Chen Y; Sheng J; Guo Y; Akinwunmi B; Zhang CJ; Ming WK
J Med Internet Res; 2021 Feb; 23(2):e22841. PubMed ID: 33493130
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study.
Teng Y; Wei Y; Chen Y; Yan J; Liu S; Li F; Bao S; Ren Y; Liu L; Yang Y
Integr Med Res; 2023 Sep; 12(3):100969. PubMed ID: 37546234
[TBL] [Abstract][Full Text] [Related]
16. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
[TBL] [Abstract][Full Text] [Related]
17. Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancer.
Hata A; Fifer S; Hasegawa K; Ando E; Kasahara-Kiritani M; Takahashi M; Ordman R; Toh L; Inoue A
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38196301
[TBL] [Abstract][Full Text] [Related]
18. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
Marshall DA; Deal K; Bombard Y; Leighl N; MacDonald KV; Trudeau M
BMJ Open; 2016 Jun; 6(6):e010981. PubMed ID: 27256091
[TBL] [Abstract][Full Text] [Related]
19. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
[TBL] [Abstract][Full Text] [Related]
20. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G
Front Psychol; 2023; 14():1062830. PubMed ID: 37425173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
